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The  pressor  substance  hypertensin,  which  is  the  product  of the  action  of 
the renal enzyme renin upon its plasma substrate, has been shown to be present 
in the arterial blood of many patients with hypertensive cardiovascular disease 
(1)  as well  as in the arterial  blood  of animals with experimental  renal hyper- 
tension (2--4). Hypertensin may, therefore, be concerned in causing the elevation 
of blood  pressure  in  both  of  these  conditions.  In  the  course  of attempts  to 
purify this material  it was found that certain preparations,  when examined by 
means  of  the  countercurrent  distribution  method,  revealed  not one but  two 
pressor substances. Further study of this completely unexpected finding showed 
that the initial pressor substance, hypertensin I, formed as a result of the action 
of  renin  on  its  substrate,  is  quickly  converted  to  a  second  substance  with 
approximately equal pressor activity, hypertensin II, apparently by an enzyme 
in plasma, which is activated by chloride ion. It is the purpose of this paper to 
describe  the preparation  of hypertensin  I  from suitable  preparations  of renin 
and  substrate,  to demonstrate  its  conversion to hypertensin  II by the action 
of the plasma enzyme, and to determine  which ions are effective in activating 
this enzyme. 
Metkods 
Preparation of Renin.--The  renin was prepared  from fresh hog kidneys according to the 
method  described by Katz and Goldblatt  (5) and modified by Dexter  (6). Tiffs preparation 
contained a considerable amount of hypertensinase activity which was eliminated (reference 7, 
page 101) in the following fashion. Renin, prepared from 100 pounds of hog kidneys by am- 
monium sulfate precipitation,  was dissolved in 1.5 liters of water. The solution was chilled 
to 0-5°C. and sufficient solid sodium chloride was added to insure complete saturation.  0.1 N 
HCI, saturated  with NaC1, wa~nthen dripped into the solution slowly and with constant stirring 
until the pH dropped to 2.0. The solution was centrifuged at high speed at 0-5°C. The super- 
natant  containing  the  hypertensinase  was  decanted  and  discarded.  The precipitate  was 
dissolved in 1 liter of cold 0.1 ~ Na,I-IPO4. The light brown solution was adjusted  to pH 7.5, 
put into small diameter  cellophane  bags, and  dialyzed  exhaustively  against  cold distilled 
water. The resulting product,  with a volume of about 1.25 liters, was found to be uniformly 
free of hypertensinase. Usually 1 volume of this enzyme preparation was adequate to catalyze 
the formation of hypertensin  in 25 volumes of the substrate  preparation  described below in 
a period of 30 to 45 minutes  when this mixture was incubated  at 37°C. and pH 7.5. 
Preparation of Substrate.--Horse blood was collected in ~0 volume of 4 per cent sodium 
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citrate and was allowed to stand for 48 hours at 0-5°C. This and subsequent steps were all 
carried out at these temperatures. The dear supematant plasma was drawn off and its pH 
adjusted to 6.0 with 1.0 ~ HC1. A 4.0 M solution of ammonium sulfate was added slowly with 
stirring until the concentration of this salt reached 1.3 ~. The solution was filtered by gravity 
and the precipitate discarded. Additional 4.0 M ammonium sulfate solution was added to the 
filtrate over a  period of several hours with continuous stirring until the salt concentration 
rose to 2.2 M. The precipitate was gathered on large Buchner funnels, resuspended, and thor- 
oughiy washed in a 2.5 M solution of (NH4hSO4. The precipitate was again collected on Buch- 
net funnels and dissolved in distilled water, the volume of which was ~  that of the original 
plasma. The temperature was brought to 25°C.  and the pH adjusted to 3.8 with 2.5 N HCI. 
These conditions were maintained for 30 minutes; during this period, residual hypertensinase 
was destroyed (reference 7, page 133).  The pH was then adjusted to 7.5 with 2.5 N NaOH 
and the solution dialyzed in an artificial kidney (8) in the cold against tap and then distilled 
water until it was completely free of ammonia and chloride. The volume at this stage was 
approximately ~  that of the original plasma and usually contained enough substrate to yield 
1.0 to 1.5 Goldbhtt units (9) of hypertensin per ml. when incubated with renin. Its pressor 
effect was assayed by intravenous injections into rats and compared to that produced by an 
injection  of  a  standardized  hypertensin  solution. 
EXPERIMENTAL 
Preparation  of  Itypertensin  I.-- 
2.5 liters of the substrate solution, free of ammonia and chloride and with a pH of 7.5, was 
warmed to 37°C.  500 ml. of renin with a similar pH and also free of ammonia and chloride was 
added to the substrate with mixing. This amount of renin is greatly in excess of the amount 
required for complete conversion of substrate and was used in this experiment only in an 
effort to demonstrate the initial product of the action of renin. After 6 minutes' incubation, 
the mixture was poured into 12 liters of 95 per cent alcohol and stirred thoroughly while the 
pH was adjusted to 5.5 with 2.5 N ttCI, the samples for determination of pH being diluted 1 to 
4 with distilled water. The precipitated proteins were removed by filtering on large gravity 
funnels and thoroughly washed with 12 liters of 80 per cent alcohol. After removal of the 
precipitate, the filtrates were combined and concentrated to a volume of 500 ml. by evapora- 
tion under reduced pressure at a temperature less than 40°C. The sohtion was then acidified 
with suflident 2.5 t~ HC1 to bring the pH to 3.0 and extracted three times with 500 ml. por- 
tions of diethyl ether. The ether extracts were discarded and the fat-free aqueous layer, after 
adjustment to a pH of 6.0 with 2.5 ~ NaOH, was further concentrated to a volume of 150 ml. 
by evaporation under reduced pressure. At this point, the solution was adjusted to a pH of 
7.0 by the addition of 2.5 N NaOH and the active material was extracted into three portions 
of n-butanol totalling 450 mL in volume. The active material was recovered from the butanol 
by extraction into one 100 ml. and two 50 ml. portions of 0.05 ~  I-IsPO4. This preliminary 
passage through butanol effected a considerable purification wi~ little loss of active material. 
The combined acid extracts, containing 3300 Goldblatt units of hypertensin, were brought to 
pH 7.0 with 2.5 N NaOH and concentrated to 25 ml. by evaporation in vacuo. This material 
was subjected to countercurrent distribution with 25 mh of 0.05 N sodium phosphate buffer 
(pH 7.0) in the lower phase, and the same volume of n-butanol in the upper. Both of the solu- 
tions were saturated with each other. The distribution apparatus used was a modification of 
the simple machine described by Craig (10)  for preliminary work. After 49 transfers, all the 
tubes were acidified by the addition of 1.0 ml. of 3 N H~PO,; time was allowed for re-equilibra- 
tion, and the inactive butanol layers were discarded.  Samples of the lower aqueous layer, 
after removal of residual butanol by evaporation and  suitable dilution,  were assayed (11) 
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The results of these assays, expressed in Goldblatt units, are shown in curve 
A, Fig. 1. The curve reveals one pressor substance contained in tubes 16 to 34, 
which has been designated hypertensin I.  The solutions from tubes numbered 
17 through 31  were pooled. After the pH was brought to 7.5 and the solution 
was concentrated  to 250 ml.  it was stored at  -20°C.  for subsequent experi- 
ments. Upon assay, this preparation was found to contain a total of 2000 Gold- 
blatt units. 
Demonstration  of  Hypertensin  H.-- 
Two 50 ml. aliquots of the solution of hypertensin I described above, containing 400 units 
each, were warmed to 37°C. and mixed at the same temperature with 400 ml. portions of sub- 
strate, one of which had been made 0.1 molar with sodium chloride, while the other remained 
salt-free. After incubation for 1 hour, each solution was mixed with 4 volumes of 95 per cent 
ethyl alcohol, brought to a pit of 5.5 with 3.0 N I-hPO~, and filtered by gravity to remove the 
precipitated protein. The precipitate was washed with 4 volumes of 80 per cent alcohol, 
again filtered by gravity, and discarded. The combined alcoholic filtrates were concentrated 
by evaporation to about 100 ml., adjusted to pH 3.0 by the addition of 3 N I-ht~4, and ex- 
tracted three times with equal volumes of ether. The ether extracts were discarded; the fat- 
free aqueous layers were adjusted to pH 7.0 and then concentrated in vacuo to a volume of 
25 ml. Each of these two preparations was subjected to a 50 tube countercurrent distribution 
exactly as described for the preparation of hypertensin I. 
The results in Fig.  1 show that hypertensin I, incubated with substrate in 
the absence of sodium chloride (curve B),  appeared in tubes  16 to 30 with a 
maximum in tube 20 and was, therefore, virtually unchanged from the starting 
material (curve A). However, the activity of the sample incubated with added 
sodium  chloride  appeared  (curve  C)  in  tubes  4  to  12,  with  a  maximum in 
tube  6.  This  fraction,  designated  hypertensin  II,  apparently  was  produced 
from hypertensin I  by the action of a plasma enzyme which was activated by 
chloride ion. Chloride ion alone will not produce this conversion, nor will boiled 
plasma with chloride present. 
Since the foregoing experiments were done with the use of horse blood and 
hog renin as starting materials, it was important to determine whether similar 
results could be obtained with human materials. This was done using a dialyzed 
non-fractionated human plasma as the substrate preparation and human renin 
prepared according to the method of Dexter (6). The human hypertensin pre- 
pared by the salt-free incubation of these materials gave a distribution pattern 
similar  to  that  of horse  hypertensin  I.  Furthermore,  the  incubation  of this 
hypertensin with human plasma containing chloride produced a  pressor mate- 
rial which yielded a  distribution pattern similar to that of horse hypertensin 
II.  It was shown,  moreover, that  a  highly purified  mixture  of horse hyper- 
tensins I  and II (5000 units per mg. of N) had a  pressor action when injected 
into humans.  A  dose of 1.5  to  2.5  units  was injected  intravenously and  the 
blood pressures were determined by auscultation. The results shown in Table I 278  TWO  FORMS  OF  HYPERTENSIN 
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indicate that the human being is quite sensitive to the pressor activity of horse 
hypertensins and that the sensitivity is not changed by repeated injection. 
Effects  of Different  Ions  on  the  Activation  of the  Substrate  Enzyme.--The 
methods used for this phase of the investigation were simpler  than those de- 
scribed in the previous experiments. 
10 ml. portions of the salt solution to be tested were added to loo ml. of a wetl dialyzed sub- 
strate. Care was taken that the pH of this mixture would be within the range 7.0-7.5. Sodium 
hydroxide or phosphoric acid was used for pH adjustments when it was not possible to use 
TABLE I 
The Effe¢b of Intravo,ous Injections of Horse Hypertensin upon the Blood Pressure  of Several 
Human Subjeas 
Patient 
LD 
SR 
DS 
MJ 
js 
J¥ 
Age 
yrS. 
41 
44 
38 
35 
46 
33 
Sex 
M. 
M. 
M. 
M. 
M. 
M. 
Dose 
umts 
2.3 
2.0 
1.5 
2.0 
2.5 
2.5 
Control blood 
pressure 
ram. Hg 
120/82 
112/80 
120/90 
120/90 
128/90 
120/70 
110/92 
108/60 
110/50 
110/54 
110/72 
108/70 
126/80 
Maximum blood 
pressure 
ram. Hg 
190/120 
180/130 
174/140 
172/130 
180/140 
160/120 
165/120 
130/80 
130/80 
125/75 
16O/lOO 
13O/lOO 
1~/1~ 
the acid or base of the salt to be tested. After adjustment of pH, the substrate-salt mixture 
was brought to 37°C., mixed with 5 ml. of well dialyzed renin, and incubated for 45 minutes. 
At the end of this period, the mixture was poured into 4 volumes of 95 per cent alcohol, stirred, 
the pH adjusted to 5.5,  and centrifuged. The precipitated proteins were discarded and the 
supernatant  fluid reduced by evaporation to 5 to 10 ml. The pH was adjusted to 8.9 with 
2.5  N sodium hydroxide, the solution was made to a  volume of 25 ml., and sufficient solid 
NaHCOB added to give a concentration of 0.t u. This solution was then subjected to counter- 
current distribution in which the lower aqueous phase consisted of 25 ml. portions of 0.1  N 
NaHCO3 and the upper phase of similar volumes of n-butanol. After 9 transfers, both phases 
of all tubes were sampled.  The aliquots were evaporated  to dryness  to eliminate butanol, 
and then suitably diluted for assay. 
Two contrasting experiments are shown in Fig. 2.  Curve A shows the hyper- 
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0.1 g  with respect to KC1. In this case nearly all of the activity was confined 
to the water phases  of tubes 0  and  1,  which had distribution coefficients of 
0.03 and 0.06. The active material was therefore identified as hypertensin II. 
Curve  B  shows  the  activity after distribution when  the  incubation mixture 
had been 0.1  ~s with respect to sodium phosphate. Here most of the activity 
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Number of lube 
FIO.  2.  10 tube countercurrent distribution. Curve B  illustrates hypertensin I  produced 
in a renin-substrate incubation free of inorganic ions. Curve A shows hypertensin II formed 
in a similar experiment  in which the mixture had been made 0.1 u with KCI. 
was found m both phases of tubes 2, 3, 4, and 5, which had distribution coeffi- 
cients of 0.19, 0.19, 0.35, and 0.21, and was, therefore, hypertensin I. Although 
the degree of resolution obtained in these short distributions did not separate 
the two types of hypertensin, it provided sufficiently good qualitative identi- 
fication. This pair of experiments shows that, although hypertensin I was formed 
in both cases by the action of renin on its substrate, hypertensin I  became con- 
verted by the plasma enzyme to hypertensin II only when chloride was present. 
The results  of exactly similar experiments using a  variety of other ions are SKEGGS~ MARSH~ KAHN~ AND  SHUMWAY  281 
given in Table II. It can be seen that, in addition to CI-, the enzyme was acti- 
vated by NO~, Br-, and F-', while HCO~, SO~', and HPO~" were without effect. 
DISCUSSION 
The conversion of hypertensin I  to hypertensin II occurs readily under the 
influence of a  non-dialyzable protein fraction of plasma in the presence of be- 
tween  0.0001  and 0.001  ~  chloride.  The chloride  ion  or the plasma fraction 
alone has been shown to be ineffective. The nature of the conversion seems to 
TABLE II 
The Effext of Various Sal~s upon l~ Type of Hypertcnsin Formed 
Experiment  No.  Salt added  Predominant  type of  hypertensm 
185 
238 
227 
208B 
186 
194A 
209B 
214A 
214B 
204 
194C 
212 
203 
205A 
205B 
199A 
199B 
194D 
No salt 
0.0001 ~ NaC1 
0.001 M  NaCI 
0.01 M  NaCI 
0.153 ~ NaC1 
0.1 ~ Na~HPO4 
0.1 M  NaHCOj 
0.1 u NaBr 
0.1 M  NaF 
0.1 u NaNO, 
0.1  ~  KCl 
O.  1 M K~SO, 
O. 1 M CaC1, 
0.1 u MgCl~ 
0.1 ~  MgSO4 
0.1 ~ (NII,),SO~ 
0.1 ~ NH4CI 
0.1 ~ LitSO4 
I 
I* 
II* 
H 
II 
I 
I 
H 
II 
II 
II 
I 
II 
II 
I 
I 
II 
I 
* These experiments yielded mixtures of the two types of hypertensin. 
be enzymatic and the necessary enzyme is present in both horse and human 
plasma. 
The activation of an enzyme by chloride is not unknown.  A polypeptidase has 
been isolated (12) from yeast which requires halide as well as zinc ions. Nitrate 
in this case will also replace halide to a  certain extent. 
Hypertensin I  has been obtained in this laboratory with a  specific activity 
of 5000 Goldblatt units per rag. of N, indicating a high degree of purity. This 
product does not give a ninhydrin reaction and yet upon acid hydrolysis yields 
a large number of ninhydrin-reacting amino acids. The compound is probably, 
therefore,  a  polypeptide.  It  is  most  natural  to  assume  that  hypertensin  II 
results from the removal of a  polar group or groups from the hypertensin I 
molecule leaving that portion of the molecule responsible for its pressor activity 
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In  theory, either  or both of these  compounds might  be of importance in 
human hypertension. It cannot be assumed that owing to the presence of the 
plasma  enzyme and  chloride  the significant  compound would necessarily be 
hypertensin II, since hypertensin I might exert its effect on the arterioles before 
being converted to hypertensin II. In any case, the interpretation of previous 
work done in this laboratory dealing  with the assay of hypertensin in the cir- 
culating blood of dogs (24)  and  humans  (1)  with hypertension probably is 
not affected by the present findings since both types of hypertensin are meas- 
ured by the methods that were used. 
SUMMARY 
Two types of hypertensin  have been demonstrated  by means  of counter- 
current distribution. The first type is the product of the action of the enzyme, 
renin,  upon its substrate and  has  been designated hypertensin  I.  It  can  be 
rapidly  converted  to  a  second  approximately  equally  pressor  compound, 
hypertensin  II,  apparently  through  the action  of an  enzyme in  the plasma 
which requires halide or nitrate for activation. 
A highly purified preparation containing horse hypertensins I and II caused 
an  elevation of blood pressure when injected into human  beings. 
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